Axogen, Inc. Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficit) - Public Offering (Details)			12 Months Ended
	Oct. 13, 2016 USD ($) shares	Oct. 07, 2016 item $ / shares shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2015 USD ($) shares
Shares of common stock sold			33,008,865	29,984,591
Net proceeds from issuance of common stock \| $			$ 18,668,092	$ 30,968,386
October 2016 Offering
Shares of common stock sold		2,333,334
Public offering price (in dollars per share) \| $ / shares		$ 7.50
Number of days to underwriter to sell additional common shares		30 days
October 2016 Offering \| Directors and officers
Shares of common stock sold		32,666
Number of directors and officers who purchased common stock \| item		5
October 2016 Offering inclusive of over-allotment option
Shares of common stock sold	2,683,334
Net proceeds from issuance of common stock \| $	$ 18,670,000
Underwriting Agreement
Shares of common stock sold	350,000	350,000